Parvin Khalili1, Fatemeh Ayoobi2, Maryam Mohamadi3, Ahmad Jamalizadeh4, Carlo La Vecchia5, Ali Esmaeili-Nadimi6. 1. Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran. 2. Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. 3. Pistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. 4. Health System Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. 5. Department of Clinical Sciences and Community Health, University degli Study di Milano, Milan, Italy. 6. Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. dr_esmaeili_n@yahoo.com.
Abstract
BACKGROUND: There are differences of opinion about the beneficial or detrimental effects of opium consumption on cardiovascular diseases (CVDs). So, we aimed to study the association between opium use and CVDs. METHODS: We used data obtained from the Rafsanjan Cohort Study (RCS), as a part of the prospective epidemiological research studies in IrAN (PERSIAN), with detailed, validated data on opium consumption and some other exposures. A total of 10,000 adults were enrolled in the study. Logistic regression models were used to assess the possible relationships of opium consumption with the prevalence of ischemic heart diseases (IHD) and myocardial infarction (MI). RESULTS: In this study, 9990 participants in the baseline phase of the Rafsanjan adult cohort study were included according to their completed questionnaire. Among all participants, 870 and 296 individuals were found to suffer from IHD and MI, respectively. Opium consumption was found to be relatively high in the RCS participants, especially in men (men = 2150 and women = 228). Opium use was associated with a higher odds of IHD and MI, with the adjusted odds ratios (95% CI) of 1.51 (1.22-1.86) and 1.79 (1.31-2.45), respectively. Also, dose-response increases were observed with the highest odds ratios in the 4th quartile for MI and IHD (p-values for trend < 0.001). Increased odds were observed for the two main methods of opium consumption, i.e. oral and smoking, but oral administration had higher odds ratio. CONCLUSIONS: Opium consumption is associated with the increased odds of both IHD and MI diseases.
BACKGROUND: There are differences of opinion about the beneficial or detrimental effects of opium consumption on cardiovascular diseases (CVDs). So, we aimed to study the association between opium use and CVDs. METHODS: We used data obtained from the Rafsanjan Cohort Study (RCS), as a part of the prospective epidemiological research studies in IrAN (PERSIAN), with detailed, validated data on opium consumption and some other exposures. A total of 10,000 adults were enrolled in the study. Logistic regression models were used to assess the possible relationships of opium consumption with the prevalence of ischemic heart diseases (IHD) and myocardial infarction (MI). RESULTS: In this study, 9990 participants in the baseline phase of the Rafsanjan adult cohort study were included according to their completed questionnaire. Among all participants, 870 and 296 individuals were found to suffer from IHD and MI, respectively. Opium consumption was found to be relatively high in the RCS participants, especially in men (men = 2150 and women = 228). Opium use was associated with a higher odds of IHD and MI, with the adjusted odds ratios (95% CI) of 1.51 (1.22-1.86) and 1.79 (1.31-2.45), respectively. Also, dose-response increases were observed with the highest odds ratios in the 4th quartile for MI and IHD (p-values for trend < 0.001). Increased odds were observed for the two main methods of opium consumption, i.e. oral and smoking, but oral administration had higher odds ratio. CONCLUSIONS: Opium consumption is associated with the increased odds of both IHD and MI diseases.
Entities:
Keywords:
Ischemic heart diseases; Myocardial infarction; Opium use; Prospective epidemiological research studies in IrAN (PERSIAN)
Authors: Jan Gryczynski; Robert P Schwartz; Shannon Gwin Mitchell; Kevin E O'Grady; Steven J Ondersma Journal: Drug Alcohol Depend Date: 2014-05-17 Impact factor: 4.492
Authors: Susan E Schober; Lisa B Mirel; Barry I Graubard; Debra J Brody; Katherine M Flegal Journal: Environ Health Perspect Date: 2006-10 Impact factor: 9.031
Authors: Hamid Najafipour; Mohammad Masoomi; Armita Shahesmaeili; Ali Akbar Haghdoost; Mahdi Afshari; Hamid Reza Nasri; Masoomeh Kahnooji; Sadra Samadi; Ali Mirzazadeh Journal: Int J Prev Med Date: 2015-05-20